Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
XIWANG PROPERTY | XSA | Mar 31, 2025 | 0.00 | 0.00 |
XL Axiata Tbk | E5F | Mar 31, 2025 | 0.11 | -6.84 |
XLMedia Plc | 7X3 | Mar 31, 2025 | 0.11 | 0.00 |
XMReality | 5LL | Mar 31, 2025 | 0.00 | 0.00 |
Xometry Inc | 0N5 | Mar 31, 2025 | 23.03 | -3.92 |
XORTX Therapeutics | ANUA | Mar 31, 2025 | 0.81 | 0.00 |
Xos | 9KR0 | Mar 31, 2025 | 4.00 | 0.00 |
XP Chemistries AB | 86Q | Mar 31, 2025 | 0.01 | 0.00 |
XP Inc. - Class A Common Stock | XP9 | Mar 31, 2025 | 12.54 | -8.20 |
XP Power Ltd | 4XP | Mar 31, 2025 | 9.35 | +0.54 |
Xped Limited | U9O0 | Mar 31, 2025 | 0.03 | -1.54 |
XPEL, Inc. | XPX | Mar 31, 2025 | 27.80 | -2.11 |
XPeng A ADR | 8XPA | Mar 31, 2025 | 19.55 | +8.01 |
XPENG INC. CL.A DL-,00001 | 8XP | Mar 31, 2025 | 9.54 | +4.84 |
Xplora Technologies | 86P | Mar 31, 2025 | 2.43 | -0.41 |
XPO Logistics Inc | UX2A | Mar 31, 2025 | 98.20 | -5.30 |
XPS PENSI.GR.PLC LS-,0005 | 406 | Mar 31, 2025 | 4.45 | -1.36 |
XR Immersive Tech | 79W | Mar 31, 2025 | 0.13 | -5.63 |
Xtacy Therapeutics | U040 | Mar 31, 2025 | 0.08 | 0.00 |
Xtant Medical Holdings Inc | XMS | Mar 31, 2025 | 0.45 | +3.21 |
XTEP INTL | 4QI | Mar 31, 2025 | 0.59 | -4.80 |
XTL Biopharmaceuticals Ltd. - American Depositary Shares | H2K2 | Mar 31, 2025 | 1.00 | +1.53 |
XTPL SA | 5C8 | Mar 31, 2025 | 26.50 | +2.51 |
Xtract Resources Plc | R9XN | Mar 31, 2025 | 0.00 | -80.56 |
XTRADEBDM | 9PR | Mar 31, 2025 | 15.90 | -0.66 |
Xunlei Limited - American Depositary Shares | 4XN | Mar 31, 2025 | 4.00 | -8.68 |
Xvivo Perfusion | 3XV | Mar 31, 2025 | 25.85 | -9.62 |
XXIX METAL CORP. | 5LW0 | Mar 31, 2025 | 0.06 | -0.81 |
XXL ASA A NK 40 | 2XX0 | Mar 31, 2025 | 1.05 | -1.36 |
Xylem Inc. | XY6 | Mar 31, 2025 | 109.30 | -1.40 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.